Related Experiment Videos

Cardiac catheterization and operative outcomes from a multicenter consortium for children with williams syndrome

Phat P Pham1, James H Moller, Christine Hills

  • 1Swedish Medical Center, 1101 Madison, Suite 800, Seattle, WA 98104, USA.

Pediatric Cardiology
|December 5, 2008
PubMed

Insights

Children with Williams syndrome (WS) and cardiovascular issues face higher mortality risks, especially with combined supravalvular aortic stenosis and pulmonary artery stenosis. This study highlights the need for careful management of these complex cardiac conditions in WS patients.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatric Medicine

Background:

  • Williams syndrome is a genetic disorder associated with a wide range of cardiovascular anomalies.
  • Limited outcome data exists for surgical and catheterization procedures in individuals with Williams syndrome due to its rarity.
  • Understanding the frequency and impact of cardiovascular lesions is crucial for managing patients with Williams syndrome.

Purpose of the Study:

  • To analyze the frequency of cardiovascular lesions in patients with Williams syndrome.
  • To assess the outcomes, specifically mortality rates, associated with cardiac catheterization and operations in this population.
  • To identify specific cardiovascular anomalies that pose the highest mortality risk in Williams syndrome.

Main Methods:

  • Retrospective review of data from 242 individuals with Williams syndrome and cardiovascular lesions from the Pediatric Cardiac Care Consortium (PCCC) between 1984 and 1999.
  • Analysis of cardiac anomalies, including supravalvular aortic stenosis (SVAS), pulmonary artery stenosis (PAS), and aortic arch hypoplasia (Arch).
  • Statistical assessment of mortality rates based on the type and combination of cardiovascular lesions.

Main Results:

  • The most common cardiovascular lesions were SVAS (169 patients), PAS (130 patients), and Arch anomalies (32 patients).
  • A total of 15 deaths were recorded among the 242 patients.
  • The highest mortality rate (15%) was observed in patients with the combination of SVAS and PAS, regardless of whether they underwent surgery or catheterization.

Conclusions:

  • This study represents the largest dataset of individuals with Williams syndrome undergoing cardiac procedures.
  • Patients with Williams syndrome and bilateral outflow tract obstruction (SVAS and PAS) experience significantly higher mortality.
  • Clinical management should focus on the risks associated with combined outflow tract obstructions in Williams syndrome patients.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...